Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2585 USD | -9.84% | -11.50% | +70.74% |
May. 17 | Jaguar Health Plans 1-for-60 Reverse Split Next Week | MT |
May. 14 | Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M | MT |
Financials (USD)
Sales 2024 * | 15.11M | Sales 2025 * | 22.66M | Capitalization | 71.4M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -21M | EV / Sales 2024 * | 4.73 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.15 x |
P/E ratio 2024 * |
-2.87
x | P/E ratio 2025 * |
-3.69
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.62% |
Latest transcript on Jaguar Health, Inc.
1 day | -9.84% | ||
1 week | -11.50% | ||
Current month | +20.40% | ||
1 month | +45.96% | ||
3 months | +230.99% | ||
6 months | -36.41% | ||
Current year | +70.74% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.2585 | -9.84% | 58,064,970 |
24-05-16 | 0.2867 | +12.39% | 31,266,489 |
24-05-15 | 0.2551 | -7.20% | 25,164,148 |
24-05-14 | 0.2749 | -5.30% | 63,969,137 |
24-05-13 | 0.2903 | -0.62% | 24,976,434 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.74% | 71.4M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- JAGX Stock